jane departure
This article was originally published in The Rose Sheet
Executive Summary
Sandy Cataldo has resigned as president of jane cosmetics, effective Aug. 2, Estee Lauder division announces. A successor has not yet been named. Cataldo, who took the helm in June 2001, was tasked with improving sales and profits for the struggling mass market teen cosmetics brand. Coinciding with her appointment, Lauder also initiated a $16 mil. restructuring of the business (1"The Rose Sheet" July 2, 2001, p. 4). In her 10 years with Lauder, Cataldo also served as VP-marketing for Clinique USA and Canada and senior VP-marketing for the Estee Lauder brand...
You may also be interested in...
Cataldo joins Bath & Body Works
Sandy Cataldo appointed Bath & Body Works senior VP of emerging markets, Limited Brands announces Aug. 30. Effective immediately, Cataldo will report to Exec VP and General Merchandise Manager Michael Stromberg. Cataldo joins BBW from Estee Lauder, where she most recently worked as president of jane cosmetics. Cataldo, who spent 10 years with Lauder also working for Clinique and Estee Lauder brands, resigned Aug. 2 (1"The Rose Sheet" Aug. 19, 2002, In Brief)...
Lauder's Jane Restructuring Effort Involves $16 Mil. Charge In Q4
Estee Lauder will take a one-time $16 mil. charge in the fiscal fourth quarter (ended June 30) for a restructuring effort aimed at boosting sales and profits for its jane brand of mass market cosmetics, President and CEO Fred Langhammer said during a conference call June 28.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.